首页> 外文期刊>The journal of trauma and acute care surgery >A novel sponge-based wound stasis dressing to treat lethal noncompressible hemorrhage
【24h】

A novel sponge-based wound stasis dressing to treat lethal noncompressible hemorrhage

机译:一种新型的基于海绵的伤口淤积敷料,用于治疗致死性不可压缩性出血

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Noncompressible hemorrhage is the leading cause of preventable death caused by hemorrhage on the battlefield. Currently, there are no hemostatic agents with the ability to control noncompressible hemorrhage. A wound stasis dressing based upon rapidly expanding cellulose minisponges (MS) was developed and tested in a lethal noncompressible model in swine, by fully transecting subclavian artery and vein. MS were compared with conventional hemostasis dressings, Combat Gauze (CG), in a randomized comparison. Methods: Sixteen 40-kg swine underwent transection of the subclavian artery and vein through a 4.5-cm aperture. After 30-second free bleeding, randomly selected MS or CG (n = 8 per group) were administered by an independent medical officer. The wound cavity was filled with either MS + no external pressure or one CG + one KERLIX gauze with 3 minutes of external pressure. One reapplication was allowed for CG. Mean arterial pressure was maintained at 60 mm Hg with 500-mL Hextend and lactated Ringer's solution intravenously administered up to a maximum of 10-L until study termination at 1 hour. Results: Mean pretreatment blood loss was similar for MS (719 mL) and CG (702 mL). Primary end points, namely, hemostasis at 4 minutes (MS, 75%; CG, 25%; p = 0.13), hemostasis at 60 minutes (MS, 100%; CG, 25%; p = 0.007), and survival at 60 minutes (MS, 100%; CG, 37.5%; p = 0.026), were improved with MS as were secondary end points, namely, total blood loss (MS, 118 mL; CG 1,242 mL; p = 0.021) and length of application time (MS, 25 seconds; CG, 420 seconds; p = 0.004). Conclusion: The use of MS is a novel approach for the rapid, simple treatment of severe noncompressible hemorrhage, which provided statistically significant improvement in hemostasis and survival 60 minutes after injury and a large reduction in blood loss, resuscitation fluid requirement, and medic treatment time compared with conventional hemorrhage control dressings in a swine model.
机译:背景:不可压缩的出血是战场上由出血引起的可预防死亡的主要原因。当前,没有止血剂具有控制不可压缩的出血的能力。通过完全切断锁骨下动脉和静脉,开发了基于快速膨胀的纤维素微海绵(MS)的伤口淤积敷料,并在猪的致死性不可压缩模型中对其进行了测试。在随机比较中,将MS与常规止血敷料Combat Gauze(CG)进行了比较。方法:对十六只40公斤重的猪通过一个4.5厘米的孔进行锁骨下动脉和静脉的横切。 30秒的自由出血后,由一名独立的医务人员管理随机选择的MS或CG(每组n = 8)。伤口腔充满MS +无外部压力或1 CG + 1 KERLIX纱布充满3分钟外部压力。允许重新申请CG。用500 mL Hextend将平均动脉压维持在60 mm Hg,并静脉内注射乳酸林格氏液,最大剂量为10 L,直到研究结束1小时。结果:MS(719 mL)和CG(702 mL)的平均预处理失血量相似。主要终点为4分钟止血(MS,75%; CG,25%; p = 0.13),60分钟止血(MS,100%; CG,25%; p = 0.007),60岁生存MS改善了分钟(MS,100%; CG,37.5%; p = 0.026),并改善了次要终点,即总失血量(MS,118 mL; CG 1,242 mL; p = 0.021)和使用时间时间(MS,25秒; CG,420秒; p = 0.004)。结论:MS的使用是一种快速,简单的治疗严重不可压缩性出血的新方法,在损伤后60分钟内止血和生存率具有统计学上的显着改善,并且失血量,复苏液需求量和医疗时间大大减少在猪模型中与传统的出血控制敷料相比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号